Therefore, MAP17 increase in tumor cells could be a mechanistic advantage that will permit tumor cells increase the glucose intake and in parallel decrease the intracellular pH and lactic acid by the increase of membrane bound transports (Carnero, 2012; Figure 4). This evidence concerns the gene PDZK1IP1 and neoplasm.